Short-term outcomes of greenlight HPS™ laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH)

Journal of Endourology

Volumn 22, Issue 10, 2008, Pages 2341-2347

  Spaliviero, Massimiliano ^a   Araki, Motoo ^a   Wong, Carson ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; CONFERENCE PAPER; FOLLOW UP; HUMAN; LASER; LASER PROSTATECTOMY; MAJOR CLINICAL STUDY; MALE; MEN'S HEALTH; MICTURITION; OPERATION DURATION; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; QUALITY OF LIFE INDEX; SEXUAL HEALTH; SYMPTOM; TRANSRECTAL ULTRASONOGRAPHY; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URETHRA STRICTURE; URINE INCONTINENCE; VAPORIZATION;

ADULT; AGED; CATHETERIZATION; DEMOGRAPHY; HUMANS; INTRAOPERATIVE CARE; LASERS, SOLID-STATE; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROSTATECTOMY; PROSTATIC HYPERPLASIA; TIME FACTORS; TREATMENT OUTCOME; VOLATILIZATION;

EID: 54249130304     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2008.9708     Document Type: Conference Paper

References (28)

1. Berry SJ, Coffey DS, Walsh PC et al.: The Development of Human Benign Prostatic Hyperplasia with Age. J Urol. 132: 474-479, 1984.
2. Levy A and Samraj GP: Benign Prostatic Hyperplasia: When to "Watch and Wait", When and How to Treat. Cleve Clin J Med. 74: S15-S20, 2007.
3. Bachmann A, Schurch L, Ruszat R et al.: Photoselective Vaporization (PVP) versus Transurethral Resection of the Prostate (TURP): A Prospective Bi-Centre Study of Perioperative Morbidity and Early Functional Outcome. Eur Urol. 48: 965-972, 2005.
4. de la Rosette J, Alivizatos G, Madersbacher S et al.: EAU guidelines on benign prostatic hyperplasia (BPH). Eur Urol. 40: 256-263, 2001.
5. Roehrborn CG, Bartsch G, Kirby R et al.: Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: a comparative, international overview. Urology. 58: 642-650, 2001.
6. Committee APG: AUA Guidelines on Management of Benign Prostatic Hyperplasia (2003). Chapter 1: Diagnosis and Treatment Recommendations. J Urol. 170: 530-547, 2003.
7. Stovsky MD, Griffiths RI and Duff SB: A Clinical Outcomes and Cost Analysis Comparing Photoselective Vaporization of the Prostate to Alternative Minimally Invasive Therapies and Transurethral Prostate Resection for the Treatment of Benign Prostatic Hyperplasia. J Urol. 176: 1500-1506, 2006.
8. Bachmann A, Ruszat R, Wyler S et al.: Photoselective Vaporization of the Prostate: The Basel Experience after 108 Procedures. Eur Urol. 47: 798-804, 2005.
9. Malek RS, R.S. K and Barrett DM: Photoselective Potassium-Titanyl- Phosphate Laser Vaporization of the Benign Obstructive Prostate: Observations on Long-Term Outcomes. J Urol. 174: 1344-1348, 2005.
10. Te AE, Malloy TR, Stein BS et al.: Photoselective Vaporization of the Prostate for the Treatment of Benign Prostatic Hyperplasia: 12-Month Results from the First United States Multicenter Prospective Trial. J Urol. 172: 1404-1408, 2004.
11. Malek RS and Nahen K: Photoselective vaporization of the prostate (PVP): KTP laser therapy of obstructive benign prostatic hyperplasia. AUA-Update. 23: 153-160, 2004.
12. Wong C, Araki M and Tonkin JB: High-Power Potassyum-Titanyl-Phosphate or Lithium Triboride Laser Photoselective Vaporization Prostatectomy for Benign Prostatic Hyperplasia: A Systematic Approach. J Endourol. 21: 1141-1144, 2007.
13. Ruszat R, Wyler S, Forster T et al.: Safety and Effectiveness of Photoselective Vaporization of the Prostate (PVP) in Patients on Ongoing Oral Anticoagulation. Eur Urol. 51: 1031-1041, 2007.
14. Sarica K, Alkan E, Luleci H et al.: Photoselective Vaporization of the Enlarged Prostate with KTP Laser: Long-Term results in 240 Patients. J Endourol. 19: 1199-1202, 2005.
15. Kuntzman RS, Malek RS, Barrett DM et al.: Potassium-Titanyl-Phosphate Laser Vaporization of the Prostate: A Comparative Functional and Pathologic Study in Canines. Urology. 48: 575-583, 1996.
16. Tasci AI, Tugcu V, Sahin S et al.: Photoselective vaporization of the prostate versus transurethral resection of the prostate for the large prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol. 22: 347-353, 2008.
17. Bouchier-Hayes DM, Anderson P, Van Appledorn S et al.: KTP laser versus transurethral resection: early results of a randomized trial. J Endourol. 20: 580-585, 2006.
18. Sandhu JS, Ng C, Vanderbrink BA et al.: High-Power Potassium-Titanyl- Phosphate Photoselective Laser Vaporization of Prostate for Treatment of Benign Prostatic Hyperplasia in Men with Large Prostates. Urology. 64: 1155-1159, 2004.
19. Rajbabu K, Chandrasekara SK, Barber NJ et al.: Photoselective Vaporization of the Prostate with the Potassium-Titanyl-Phosphate Laser in Men with Prostates of >100 mL. BJU Int. 100: 593-598, 2007.
20. Woo H, Reich O, Bachmann A et al.: Outcome of greenlight HPS 120-W laser therapy in specific patient populations: those in retention, on anticoagulants, and with large prostates (> 80 ml). Eur Urol. Suppl. 7: 378-383, 2008.
21. Muir GH, Gomez Sancha F, Bachmann A et al.: Techniques and training with greenlight HPS 120-W laser therapy of the prostate: position paper. Eur Urol. Suppl.7: 370-377, 2008.
22. Malek RS, Kuntzman RS and Barrett DM: High power potassium-titanyl- phosphate laser vaporization prostatectomy. J Urol. 163: 1730-1733, 2000.
23. Kuntzman RS, Malek RS, Barrett DM et al.: High-Power (60-Watt) Potassium-Titanyl-Phosphate Laser Vaporization Prostatectomy in Living Canines and in Human and Canine Cadavers. Urology. 49: 703-708, 1997.
24. Lloyd SN, Collins GN, McKelvie GB et al.: Predicted and Actual Change in Serum PSA following Prostatectomy for BPH. Urology. 43: 472-479, 1994.
25. Stamey TA, Yang N, Hay AR et al.: Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate. N Engl J Med. 317: 909-916, 1987.
26. Tinmouth WW, Habib E, Kim SC et al.: Change in Serum Prostate Specific Antigen Concentration after Holmium Laser Enucleation of the Prostate: a Marker for Completeness of Adenoma Resection? J Endourol. 19: 550-554, 2005.
27. Te AE, Malloy TR, Stein BS et al.: Impact of Prostate-Specific Antigen Level and Prostate Volume as Predictors of Efficacy in Photoselective Vaporization Prostatectomy: Analysis and Results of an Ongoing Prospective Multicentre Study at 3 Years. BJU Int. 97: 1229-1233, 2006.
28. Ahmed HU, Thwaini A, Shergill IS et al.: Greenlight Prostatectomy: A Challenge to the Gold Standard? A Review of KTP Photoselective Vaporization of the Prostate. Surg Laparosc Endosc Percutan Tech. 17: 156-163, 2007.